These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 63266)

  • 41. Interactions of hepatitis B virus with hepatocytes: mechanism and clinical relevance.
    Theilmann L; Goeser T
    Hepatogastroenterology; 1991 Feb; 38(1):10-3. PubMed ID: 1709133
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Prophylactic effectiveness of human gamma globulin in viral hepatitis].
    Shifrin IA
    Voen Med Zh; 1981 Feb; (2):74-6. PubMed ID: 6165140
    [No Abstract]   [Full Text] [Related]  

  • 43. [Immunoprophylaxis of hepatitis B].
    Villeneuve JP
    Union Med Can; 1984 Dec; 113(12):1020-3. PubMed ID: 6083645
    [No Abstract]   [Full Text] [Related]  

  • 44. Prevention of hepatocellular carcinoma by universal vaccination against hepatitis B virus: the effect and problems.
    Chang MH; Chen TH; Hsu HM; Wu TC; Kong MS; Liang DC; Ni YH; Chen CJ; Chen DS;
    Clin Cancer Res; 2005 Nov; 11(21):7953-7. PubMed ID: 16278421
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Viral hepatitis: some thoughts and a summary.
    MacCallum FO
    Am J Med Sci; 1975; 270(2):411-2. PubMed ID: 192078
    [No Abstract]   [Full Text] [Related]  

  • 46. Waning-off effect of serum hepatitis B surface antibody amongst Taiwanese university students: 18 years post-implementation of Taiwan's national hepatitis B vaccination programme.
    Su FH; Chen JD; Cheng SH; Sung KY; Jeng JJ; Chu FY
    J Viral Hepat; 2008 Jan; 15(1):14-9. PubMed ID: 18088240
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Hepatitis B vaccination].
    Descoeudres C
    Schweiz Med Wochenschr; 1984 Apr; 114(15):498-505. PubMed ID: 6729415
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prevention of hepatitis B in nonresponders to initial hepatitis B virus vaccination.
    Sjogren MH
    Am J Med; 2005 Oct; 118 Suppl 10A():34S-39S. PubMed ID: 16271539
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Viral hepatitis. Modern aspects of serological diagnosis and prevention].
    Gerok W
    Med Welt; 1982 Jan; 33(3):77-83. PubMed ID: 6280016
    [No Abstract]   [Full Text] [Related]  

  • 50. The burden of viral hepatitis in Africa.
    Bojuwoye BJ
    West Afr J Med; 1997; 16(4):198-203. PubMed ID: 9473953
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Live attenuated vaccine for hepatitis A.
    Feinstone SM; Daemer RJ; Gust ID; Purcell RH
    Dev Biol Stand; 1983; 54():429-32. PubMed ID: 6317493
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cytokine-dependent anti-viral role of CD4-positive T cells in therapeutic vaccination against chronic hepatitis B viral infection.
    Ren F; Hino K; Yamaguchi Y; Funatsuki K; Hayashi A; Ishiko H; Furutani M; Yamasaki T; Korenaga K; Yamashita S; Konishi T; Okita K
    J Med Virol; 2003 Nov; 71(3):376-84. PubMed ID: 12966542
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Passive and active immunization against hepatitis B virus infection: optimal scheduling in healthy young adults.
    Minuk GY; Bohme CE; Bowen TJ
    Clin Invest Med; 1989 Jun; 12(3):175-80. PubMed ID: 2743636
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Efficacy of vaccination against viral hepatitis type B in children with the nephrotic syndrome.
    Szajner-Milart I; Zajaczkowska M; Zinkiewicz Z; Borzecka H; Majewski M
    Ann Univ Mariae Curie Sklodowska Med; 2003; 58(1):402-8. PubMed ID: 15315023
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Prevention of viral hepatitis with immunoglobulins].
    Nishioka K
    Nihon Rinsho; 1977 Apr; 35(4):1715-9. PubMed ID: 69733
    [No Abstract]   [Full Text] [Related]  

  • 56. [Infectious hepatitis. The virus, epidemiology and prevention].
    De Groote J
    Ann Soc Belg Med Trop; 1982 Dec; 62(4):281-90. PubMed ID: 6301389
    [No Abstract]   [Full Text] [Related]  

  • 57. Absence of active immunization against infectious hepatitis; follow-up study after administration of gamma globulin.
    WEHRLE PF; HAMMON WM
    J Am Med Assoc; 1958 Aug; 167(17):2062-5. PubMed ID: 13563209
    [No Abstract]   [Full Text] [Related]  

  • 58. Prevention of acute and chronic liver disease through immunization: hepatitis B and beyond.
    Margolis HS
    J Infect Dis; 1993 Jul; 168(1):9-14. PubMed ID: 8515136
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Viral hepatitis--a triumphant triennial.
    Bradley SE
    Am J Med; 1978 Jul; 65(1):1-3. PubMed ID: 210661
    [No Abstract]   [Full Text] [Related]  

  • 60. Epidemiological investigations on viral hepatitis in preschool and school communities. Note II. Evaluation of the prophylactic efficiency of standard gammaglobulin administration.
    Pănoiu L; Dobrescu A; Petrescu R; Sternberg I; Dinescu G; Ionescu C; Bărbulescu V; Both R
    Virologie; 1979; 30(2):103-7. PubMed ID: 88794
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.